- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 18 Reference Ions Near m/z 419.2485
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000063160 Reliable | 419.2551 | 419.2551 ~ 419.2551 MzDiff: 0.2 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
4.44 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000043106 Reliable | 419.2567 | 419.2565 ~ 419.2569 MzDiff: 2.0 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
9.49 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000057538 Unreliable | 419.2568 | 419.2566 ~ 419.2569 MzDiff: 1.0 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.14 (100%) | Homo sapiens [UBERON:0007779] transudate |
MSI_000043880 Unreliable | 419.258 | 419.258 ~ 419.2581 MzDiff: 0.2 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
2.77 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000045847 Unreliable | 419.258 | 419.258 ~ 419.2581 MzDiff: 0.2 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
2.77 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000047077 Unreliable | 419.2571 | 419.2571 ~ 419.2571 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
2.86 (100%) | Homo sapiens [UBERON:0013067] colorectal mucosa |
MSI_000047224 Unreliable | 419.2485 | 419.2485 ~ 419.2485 MzDiff: none |
Phyllanthin (BioDeep_00000182403) Formula: C24H34O6 (418.2355) |
2.54 (100%) | Homo sapiens [UBERON:0013067] colorectal mucosa |
MSI_000048500 Unreliable | 419.258 | 419.258 ~ 419.2581 MzDiff: 0.2 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
2.77 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000061828 Unreliable | 419.2561 | 419.2561 ~ 419.2562 MzDiff: 0.2 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.47 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000049510 Unreliable | 419.258 | 419.258 ~ 419.258 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.63 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000049520 Unreliable | 419.258 | 419.258 ~ 419.258 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.63 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000051636 Unreliable | 419.258 | 419.258 ~ 419.258 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.63 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000058624 Unreliable | 419.2554 | 419.2551 ~ 419.2558 MzDiff: 2.9 ppm |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
0.38 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000065308 Unreliable | 419.257 | 419.257 ~ 419.257 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
2.56 (100%) | Homo sapiens [UBERON:0001155] colon |
MSI_000025132 Unreliable | 419.2566 | 419.2566 ~ 419.2566 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
1.72 (100%) | Mus musculus [UBERON:0004269] upper arm connective tissue |
MSI_000055943 Unavailable | 419.2581 | 419.2581 ~ 419.2581 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
-0.41 (100%) | Homo sapiens [UBERON:0007779] transudate |
MSI_000059997 Unavailable | 419.2558 | 419.2558 ~ 419.2558 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
-0.79 (100%) | Mus musculus [UBERON:0002298] brainstem |
MSI_000060593 Unavailable | 419.2558 | 419.2558 ~ 419.2558 MzDiff: none |
CPA(18:1(9Z)/0:0) (BioDeep_00000028348) Formula: C21H39O6P (418.2484) |
-0.33 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
Found 11 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 1.6) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 1.9) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Phyllanthin Formula: C24H34O6 (418.2355) Adducts: [M+H]+ (Ppm: 6.9) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 0.3) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
Phyllanthin Formula: C24H34O6 (418.2355) Adducts: [M+H]+ (Ppm: 13.6) |
Homo sapiens (colorectal adenocarcinoma) |
80TopL, 50TopR, 70BottomL, 60BottomR-profileResolution: 17μm, 137x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
Phyllanthin Formula: C24H34O6 (418.2355) Adducts: [M+H]+ (Ppm: 13.6) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 6.2) |
Homo sapiens (colorectal adenocarcinoma) |
439TopL, 409TopR, 429BottomL, 419BottomR-profileResolution: 17μm, 157x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
Palosuran Formula: C25H30N4O2 (418.2369) Adducts: [M+H]+ (Ppm: 10.9) |
Homo sapiens (NA) |
160TopL,130TopR,150BottomL,140BottomR-profileResolution: 17μm, 142x136
|
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 0.3) |
Mus musculus (brain) |
Brain01_Bregma-3-88b_centroidResolution: 17μm, 265x320
|
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 1) |
Mus musculus (brain) |
Brain01_Bregma1-42_02_centroidResolution: 17μm, 434x258
|
|
CPA(18:1(9Z)/0:0) Formula: C21H39O6P (418.2484) Adducts: [M+H]+ (Ppm: 1.4) |
Mus musculus (brain) |
Brain02_Bregma1-42_03Resolution: 17μm, 483x403
|
|